Feeds › Merger clearances (HSR)
Merger clearances (HSR)
Mergers and acquisitions the FTC and Justice Department cleared early under the Hart-Scott-Rodino Act, with the public companies among them. Granted requests only.
About this data
- What it is
- Companies planning a merger or acquisition above a size threshold must tell the FTC and the Justice Department first and wait 30 days before closing (the Hart-Scott-Rodino Act). The parties can ask for that wait to end early, and when the agencies agree, the FTC publishes an early termination notice. This feed lists those notices: the buyer, the target, the entities being acquired and the day early termination was granted. We match each name to a public company when it lines up.
- Who files it
- The FTC, which publishes a notice once it and the Department of Justice have granted the request.
- How current
- We check the FTC's list every day. A notice is published when early termination is granted, which is before the deal closes.
- Terms
- Hart-Scott-RodinoThe Hart-Scott-Rodino Act requires companies planning a merger or acquisition above a size threshold to tell the FTC and the Justice Department first and wait 30 days before closing, so the agencies can look for competition problems.Early terminationThe parties can ask for that waiting period to end sooner. When the agencies agree, the FTC publishes an early termination notice. It means the deal was cleared to close early, not that the agencies endorse it.Possible matchWe match each name to a public company automatically. A name that matches closely is shown as a company; a looser match is marked "possible match" because a similar name, a subsidiary or a differently spelled name can be matched wrongly. Most parties are private companies and funds and have no match.
- Worth knowing
- This is a partial list of deals, not every merger. Only requests that were granted appear: deals that waited out the full 30 days, deals whose request was refused and deals that were never reportable are not listed. The FTC granted no early terminations from February 2021 until the new HSR form took effect in February 2025, so there is nothing between those dates. A notice does not mean the agencies endorse a deal, and it does not say whether the deal closed. Most buyers and targets are private companies, funds or people. We match names to public companies automatically; a looser match is marked "possible match" because a similar name, a subsidiary or a differently spelled name can be matched wrongly.
This comes from the FTC's list of early-termination notices.
Source and freshness · Information, not investment advice (disclaimer).
Early terminations granted per month, last 24 months
Only granted requests are listed, not every deal. The FTC granted none from February 2021 until the new HSR form took effect in February 2025.
Latest early terminations granted
Showing: ticker JNJ
Only early terminations that were granted are listed, not every deal, and none were granted between February 2021 and February 2025.
| Granted | BuyerThe "acquiring person" in the filing: the ultimate parent entity of the buyer, which can be a company, a fund or a person. We match each name to a public company automatically. A name that matches closely is shown as a company; a looser match is marked "possible match" because a similar name, a subsidiary or a differently spelled name can be matched wrongly. Most parties are private companies and funds and have no match. | TargetThe "acquired person": the ultimate parent entity of the target. The entities actually being acquired are listed under it. | Transaction | Source |
|---|---|---|---|---|
| Jun 22, 2020 | Johnson & Johnson | Fate Therapeutics, Inc. | 20201131 | FTC ↗ |
| Feb 25, 2019 | Johnson & Johnson | MeiraGTx Holdings plc MeiraGTx UK II Limited | 20190827 | FTC ↗ |
| Dec 17, 2018 | Gryphon Partners V, L.P. | Johnson & Johnson Cilag GmbH International | 20190512 | FTC ↗ |
| Oct 26, 2018 | Johnson & Johnson | Arrowhead Pharmaceuticals, Inc. | 20190039 | FTC ↗ |
| Jul 2, 2018 | Fortive Corporation | Johnson & Johnson Advanced Sterilization Products Services Inc.; Ethicon, Inc. | 20181508 | FTC ↗ |
| Jun 6, 2018 | Johnson & Johnson | HC2 Holdings, Inc. BeneVir Biopharm Inc. | 20181275 | FTC ↗ |
| Jun 5, 2018 | Vivus, Inc. | Johnson & Johnson Janssen Pharmaceuticals, Inc. | 20181261 | FTC ↗ |
| Apr 27, 2018 | Riccardo Braglia | Johnson & Johnson Actelion Pharmaceuticals Ltd. | 20181051 | FTC ↗ |
| Apr 6, 2018 | Platinum Equity Capital Partners IV. L.P. | Johnson & Johnson Lifescan, Inc. | 20181021 | FTC ↗ |
| Sep 27, 2017 | Integra LifeSciences Holdings Corporation | Johnson & Johnson | 20170803 | FTC ↗ |
| Aug 21, 2017 | Johnson & Johnson | TearScience, Inc. | 20171724 | FTC ↗ |
| Aug 21, 2017 | Johnson & Johnson | Bavarian Nordic A/S | 20171772 | FTC ↗ |
| Mar 13, 2017 | Johnson & Johnson | Torax Medical, Inc. | 20170815 | FTC ↗ |
| Mar 3, 2017 | Johnson & Johnson | R&D NewCo | 20170721 | FTC ↗ |
| Mar 25, 2016 | SK Capital Partners IV-A, L.P. | Johnson & Johnson Noramco, Inc.; Tasmanian Alkaloids Pty. Ltd. and 1 more | 20160895 | FTC ↗ |
| Nov 30, 2015 | Johnson & Johnson | Hanmi Pharmaceutical Co., Ltd. ANIP possible match | 20160283 | FTC ↗ |
| Nov 25, 2015 | Johnson & Johnson | Novira Therapeutics, Inc. | 20160268 | FTC ↗ |
| Sep 14, 2015 | Johnson & Johnson | Alligator Bioscience AB | 20151549 | FTC ↗ |
| Sep 1, 2015 | Teodor Gelov | Johnson & Johnson Johnson & Johnson Consumer, Inc. | 20151575 | FTC ↗ |
| Jun 26, 2015 | Johnson & Johnson | Achillion Pharmaceuticals, Inc. | 20151115 | FTC ↗ |
| Apr 16, 2015 | Cardinal Health, Inc. | Johnson & Johnson Flexible Stenting Solutions, Inc.; Cordis Corporation | 20150739 | FTC ↗ |
| Jan 22, 2015 | Johnson & Johnson | MacroGenics, Inc. | 20150437 | FTC ↗ |
| Dec 12, 2014 | Johnson & Johnson | Geron Corporation | 20150247 | FTC ↗ |
| Nov 4, 2014 | Johnson & Johnson | Aduro Biotech, Inc. | 20150098 | FTC ↗ |
| Aug 14, 2013 | Johnson & Johnson | Aragon Pharmaceuticals, Inc. | 20131012 | FTC ↗ |
| Dec 26, 2012 | Sanofi | Johnson & Johnson McNeil-PPC, Inc. | 20130433 | FTC ↗ |
| Nov 13, 2012 | Johnson & Johnson | Astellas Pharma Inc. | 20130063 | FTC ↗ |
| Oct 22, 2012 | Gores Capital Partners III, L.P. | Johnson & Johnson Ortho-Clinical Diagnostics, Inc.; Therakos, Inc. | 20130045 | FTC ↗ |
| Sep 27, 2012 | Valeant Pharmaceuticals International, Inc. | Johnson & Johnson Johnson & Johnson Consumer Companies, Inc. | 20121360 | FTC ↗ |
| Sep 21, 2012 | Johnson & Johnson | Genmab A/S | 20121338 | FTC ↗ |
| Dec 9, 2011 | Valeant Pharmaceuticals International, Inc. | Johnson & Johnson Janssen Pharmaceuticals, Inc. | 20111224 | FTC ↗ |
| Nov 1, 2011 | Johnson & Johnson | Great Hill Equity Partners IV, LP Refresh Holdings, Inc. | 20120012 | FTC ↗ |
| Aug 19, 2011 | SPC Partners IV, L.P. | Johnson & Johnson McNeil-PPC, Inc. | 20111258 | FTC ↗ |
| Dec 27, 2010 | Prestige Brands Holdings, Inc. | Johnson & Johnson McNEIL-PPC, Inc. | 20110393 | FTC ↗ |
| Dec 14, 2010 | Water Street Healthcare Partners II, L.P. | Johnson & Johnson OraPharma, Inc. | 20110317 | FTC ↗ |
| Jul 14, 2010 | Johnson & Johnson | Diamyd Medical AB | 20100857 | FTC ↗ |
| May 7, 2010 | GTCR Fund IX/A, L.P. | Johnson & Johnson Artemis Medical, Inc.; Ethicon Endo-Surgery | 20100646 | FTC ↗ |
| Jan 12, 2010 | Johnson & Johnson | Acclarent, Inc. | 20100308 | FTC ↗ |
| Jun 17, 2009 | Johnson & Johnson | Cougar Biotechnology, Inc. | 20090514 | FTC ↗ |
| Oct 24, 2008 | Johnson & Johnson | Chrysalis Ventures II, L.P. HealthMedia, Inc. | 20090055 | FTC ↗ |
| Sep 16, 2008 | Johnson & Johnson | SurgRx, Inc. | 20081684 | FTC ↗ |
| Sep 8, 2008 | JPMorgan Chase & Co. | Johnson & Johnson Ethicon, Inc. | 20081707 | FTC ↗ |
| Aug 29, 2008 | Johnson & Johnson | Amgen Inc. | 20081597 | FTC ↗ |
| Oct 1, 2007 | Johnson & Johnson | Isis Pharmaceuticals, Inc. IONS possible match | 20072164 | FTC ↗ |
| Jan 8, 2007 | Johnson & Johnson | Conor MedSystems, Inc. | 20070550 | FTC ↗ |
| Dec 12, 2006 | Johnson & Johnson | Pfizer Inc. CHC Direct LLC; Parke, Davis & Company LlC and 6 more | 20061437 | FTC ↗ |
| Nov 3, 2006 | Chattem, Inc. | Johnson & Johnson | 20070183 | FTC ↗ |
| Dec 1, 2005 | Johnson & Johnson | Biovail Corporation Biovail Laboratories International SRL | 20060196 | FTC ↗ |
| Nov 2, 2005 | Johnson & Johnson | Guidant Corporation | 20050520 | FTC ↗ |
| May 6, 2005 | Johnson & Johnson | Peninsula Pharmaceuticals, Inc. | 20050904 | FTC ↗ |
The newest 50 items, most recent first. Each row links to the FTC page that lists the notices; the transaction number identifies it there. Updated Nov 15, 2026, 5:42 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances